Jump to content
Wikipedia The Free Encyclopedia

Tetracyclic antidepressant

From Wikipedia, the free encyclopedia
(Redirected from Tetracyclic antidepressants)
Class of pharmaceutical drugs
Not to be confused with Tetracycline or Tricyclic antidepressant.
Chemical structure of the TeCA mirtazapine. Notice its four rings fused together.

Tetracyclic antidepressants (TeCAs) are a class of antidepressants that were first introduced in the 1970s. They are named after their tetracyclic chemical structure, containing four rings of atoms, and are closely related to the tricyclic antidepressants (TCAs), which contain three rings of atoms.

List of TeCAs

[edit ]

Marketed

[edit ]

Drugs that contain four rings not all fused together but are sometimes still classified as TeCAs include:

Miscellaneous

[edit ]
  • Benzoctamine (Tacitin) – a tetracyclic compound and is closely related to maprotiline, with the two compounds differing only in the length of their side chain, but benzoctamine is not used as an antidepressant and is instead used as an anxiolytic
  • Loxapine (Adasuve, Loxitane) – a typical antipsychotic that produces amoxapine as a major metabolite and is said to have antidepressant effects, but it is not usually regarded as a TeCA

Drugs that contain four rings not all fused together but could still be classified as tetracyclic include:

Never marketed

[edit ]

Drugs that contain four rings not all fused together but could still be classified as tetracyclic include:

  • Ciclazindol (WY-23,409) – a close analogue of mazindol

Pharmacology

[edit ]

TeCAs have diverse pharmacology and differ from TCAs in a number of ways. With the exception of amoxapine, TeCAs do not inhibit the reuptake of serotonin [citation needed ]. However, aside from mirtazapine, they do inhibit the reuptake of norepinephrine [citation needed ]. TeCAs block the serotonin 5-HT2 receptors similarly to TCAs. Besides mirtazapine, they also block the α1-adrenergic receptor [citation needed ]. Conversely, whereas TCAs have relatively low affinity for the α2-adrenergic receptor, mianserin and mirtazapine potently antagonize this receptor, and this action is thought to be involved in their antidepressant effects[citation needed ]. TeCAs block the histamine H1 receptor similarly to the TCAs, but tend to be even stronger antihistamines than TCAs[citation needed ]. On the other hand, in contrast to almost all TCAs, TeCAs have only low affinity for the muscarinic acetylcholine receptors, and for this reason, are associated with few or no anticholinergic side effects [citation needed ]. Mianserin and mirtazapine are far less toxic than TCAs in overdose.[1] [2]

Binding profiles

[edit ]

The binding profiles of various TeCAs in terms of their affinities (Ki, nM) for various receptors and transporters are as follows:[3]

Compound SERT Tooltip Serotonin transporter NET Tooltip Norepinephrine transporter DAT Tooltip Dopamine transporter 5-HT1A 5-HT2A 5-HT2B 5-HT2C 5-HT3 5-HT6 5-HT7 α1 α2 D2 H1 H2 mACh Tooltip Muscarinic acetylcholine receptor
Amoxapine 58 16 4,310 ND 0.5 ND 2.0 ND 6.0–50 41 50 2,600 3.6–160 7.9–25 ND 1,000
Maprotiline 5,800 11–12 1,000 ND 51 ND 122 ND ND 50 90 9,400 350–665 0.79–2.0 776 570
Mianserin 4,000 71 9,400 400–2,600 1.6–20 1.6–55 0.63–6.5 5.8–300 55–81 48–56 34 3.8–73 ≥2,100 0.30–1.7 437 820
Mirtazapine >10,000 ≥4,600 >10,000 ≥3,330 6.3–69 200 8.9–39 7.9 ND 265 316–1,815 18–88 >5,454 0.14–1.6 >10,000 670
Setiptiline >10,000 220 >10,000 ND ND ND ND ND ND ND ND 24 ND ND ND ND
Values are Ki (nM). The smaller the value, the more strongly the drug binds to the site. For assay species and references, see the individual drug articles. Most but not all values are for human proteins.

The TeCAs act as antagonists or inverse agonists of the receptors and as inhibitors of the transporters.

See also

[edit ]

References

[edit ]
  1. ^ Shaw, W. L. (1980年01月01日). "The comparative safety of mianserin in overdose". Current Medical Research and Opinion. 6 (sup7): 44–51. doi:10.1185/03007998009114803. ISSN 0300-7995.
  2. ^ Waring, W. Stephen; Good, Alison M.; Bateman, D. Nicholas (2007年01月01日). "Lack of significant toxicity after mirtazapine overdose: A five-year review of cases admitted to a regional toxicology unit". Clinical Toxicology. 45 (1): 45–50. doi:10.1080/15563650601005837. ISSN 1556-3650. PMID 17357381. S2CID 28546654.
  3. ^ Roth, BL; Driscol, J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.
SSRIs Tooltip Selective serotonin reuptake inhibitors
SNRIs Tooltip Serotonin–norepinephrine reuptake inhibitors
NRIs Tooltip Norepinephrine reuptake inhibitors
NDRIs Tooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAs Tooltip Noradrenergic and specific serotonergic antidepressants
SARIs Tooltip Serotonin antagonist and reuptake inhibitors
SMS Tooltip Serotonin modulator and stimulators
Others
TCAs Tooltip Tricyclic antidepressants
TeCAs Tooltip Tetracyclic antidepressants
Others
Non-selective
MAOA Tooltip Monoamine oxidase A-selective
MAOB Tooltip Monoamine oxidase B-selective
Miscellaneous
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
H1
Agonists
Antagonists
H2
Agonists
Antagonists
H3
Agonists
Antagonists
H4
Agonists
Antagonists
DAT Tooltip Dopamine transporter
(DRIs Tooltip Dopamine reuptake inhibitors)
NET Tooltip Norepinephrine transporter
(NRIs Tooltip Norepinephrine reuptake inhibitors)
SERT Tooltip Serotonin transporter
(SRIs Tooltip Serotonin reuptake inhibitors)
VMATs Tooltip Vesicular monoamine transporters
Others
mAChRs Tooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(and prodrugs)
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT3 7
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Classes
Antibiotics
Antidepressants
(TeCAs)
Steroids

AltStyle によって変換されたページ (->オリジナル) /